This interplay highlights the therapeutic potential of targeting the AhR-Nrf2 pathway to counteract the detrimental effects of the STAT3 pathway in AD and offers a novel approach for restoring skin barrier integrity and reducing inflammation. The gene discussed is NFE2L2; the disease is Alzheimer disease.